Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate for mitochondrial myopathies
2012-002692-34Phase 2Completed
- Sponsor
- Heidelberg University Children's Hospital
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bezafibrate in Mitochondrial myopathies (MM) and Mitochondriopathy, sponsored by Heidelberg University Children's Hospital. Started Feb 2013; status: completed.
02
Drugs
bezafibrate
03
Conditions
Mitochondrial myopathies (MM)Mitochondriopathy
Beyond the preview
Go deeper on 2012-002692-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002692-34.